BDCs have been unfairly beaten up by a market that doesn't fully appreciate credit investing or how to evaluate it. Read ...

Approval based on pivotal Phase 3 C-POST trial showing Libtayo significantly reduced the risk of disease recurrence or death by 68% compared to placebo (hazard ratio: 0.32; 95% confidence interval: 0.

Raising a child can cost over $300,000 from birth to age 17. Here's how to build a financial foundation for your family without losing sight of your long-term goals.

Today's average mortgage rate on a 30-year fixed-rate mortgage is 6.37%, up 0.03% from the previous week, according to the ...

Good afternoon, thank you for attending today's Penguin Solutions Fourth Quarter and Full Year 2025 Financial Results. My name is Victoria, and I'll be your moderator today. I would now like to pass ...

In the past year, an AI made millions in cryptocurrency. It's written the gospel of its own pseudo-religion and counts tech ...

The way I preach it is that God draws straight with crooked lines. God is so powerful that he can create a narrative, a story in which creatures rebel against him, and they are responsible for that ...

Now that the details of Budget 2026 have been revealed, you may have questions about how the measures within it will impact ...

Fixed income assets are poised for strong performance over the next year. Churchil Bhatt of Kotak Mahindra Life Insurance ...

According to a new report from NIVA, dubbed the “State of Live,” it's estimated that a mere 20% of indie music venues, ...

Approval based on pivotal Phase 3 C-POST trial showing Libtayo significantly reduced the risk of disease recurrence or death by 68% compared to ...

In the U.S., the generic name for Libtayo in its approved indications is cemiplimab-rwlc, with rwlc as the suffix designated in accordance with Nonproprietary Naming of Biological Products Guidance ...